Emla and Zygomycosis - a phase IV clinical study of FDA data
We study 8,621 people who take Emla or have Zygomycosis. No report of Zygomycosis is found in people who take Emla.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Emla?
Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 4,653 Emla users for its effectiveness, alternative drugs and more.
What is Zygomycosis?
Zygomycosis (an infection caused by fungus) is found to be associated with 639 drugs and 602 conditions by eHealthMe.
Do you take Emla and have Zygomycosis?Check whether Zygomycosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Zygomycosis and when was it recovered:
Expand to all the drugs that have ingredients of lidocaine; prilocaine:
Alternative drugs to, pros and cons of Emla:
- Emla (4,653 reports)
Zygomycosis treatments and more:
- Zygomycosis (3,968 reports)
COVID vaccines that are related to Zygomycosis:
- Zygomycosis in Moderna COVID Vaccine
- Zygomycosis in Pfizer BioNTech Covid Vaccine
- Zygomycosis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Zygomycosis:
All the conditions that are associated with Zygomycosis:
How the study uses the data?
The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Flonase and Oedema Mouth - 11 seconds ago
- Acetylcysteine and Spiriva drug interaction - 13 seconds ago
- Erwinaze and Pulmonary Embolism - 20 seconds ago
- Atrovent and Multi-Organ Failure - 21 seconds ago
- Weight Increased and drugs of ingredients of dofetilide - 27 seconds ago
- Ultracet and High Blood Cholesterol - 29 seconds ago
- Drisdol and Nasal Congestion - 34 seconds ago
- Fish Oil and Punctate Keratitis - 45 seconds ago
- Gleevec and Lodine drug interaction - 46 seconds ago
- Testosterone Cypionate and Weakness - 48 seconds ago